MASIMO CORPORATION for MASIMO CORPORATION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Support for patent reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
| PAUL ORDAL | — |
Health Issues HCR
Support for continuous monitoring of patients taking opioids and patient safety in general; Government Purchasing Organizations (GPOs) and anti-competitive behavior in the medical device supply chain; Fiscal Year 2022 Labor-Health and Human Services, Education spending bill: Study of continuous monitoring for patients taking opioids; Remote patient monitoring technology; Medicare coverage and reimbursement and pilot projects
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
| PAUL ORDAL | — |
Consumer Issues/Safety/Products CSP
Dangers of reprocessed medical devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| CATHERINE MEIER | — |
| PAUL ORDAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.